Soligenix, Inc. (SNGX) key performance indicators and operating metrics (1 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Phase 3 FLASH2 Confirmatory Trial Patients Enrolled | 169.00 | FY2026-Q1 |
Back to SNGX overview · SNGX earnings · SNGX holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.